Filing Flows › AdaptHealth (AHCO) › Q2 2026 › vs Q1 2026
AdaptHealth (AHCO) Q2 2026 vs Q1 2026 (quarter over quarter)
AdaptHealth's revenue fell $79.5M (-10%) from $820M in Q1 2026 to $740M in Q2 2026. The biggest changes: Sleep Health +$28.0M (+8%); Wellness at Home +$18.4M (+13%); Respiratory Health +$16.3M (+9%).
AdaptHealth, Q2 2026: revenue $740M (+13% year over year), operating margin -18.6%, net loss $133M, operating cash flow $145M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Sleep Health | $386M | $358M | $28.0M | +8% |
| Respiratory Health | $194M | $178M | $16.3M | +9% |
| Wellness at Home | $159M | $141M | $18.4M | +13% |
| Revenue | $740M | $820M | −$79.5M | -10% |
| Income tax benefit | $21.2M | $5.2M | $16.0M | +306% |
| Net loss | $133M | $14.9M | $118M | +792% |
| Costs & expenses | $894M | $840M | $54.3M | +6% |
| Operating costs | $878M | $814M | $63.8M | +8% |
| Interest & other, net | $16.1M | $25.6M | −$9.4M | -37% |
| Cost of revenue | $636M | $708M | −$72.2M | -10% |
| General & admin | $96.1M | $95.9M | $185K | +0.2% |
| Other operating costs | $146M | $10.1M | $136M | 14× |
| Operating cash sources | $278M | $109M | $169M | +156% |
| Depreciation & amortization | $120M | $106M | $13.8M | +13% |
| Share-based compensation | $5.6M | $6.5M | −$975K | -15% |
| Working capital & other | $152M | −$4.4M | $157M | — |
| Net loss absorbed | $133M | $14.9M | $118M | +792% |
| Operating cash flow | $145M | $93.7M | $51.6M | +55% |
| Capital expenditures | $166M | $121M | $45.0M | +37% |
| Negative free cash flow (OCF − capex) | $20.9M | $27.5M | −$6.5M | -24% |
Questions
How much did AdaptHealth's revenue grow quarter over quarter in Q2 2026?
AdaptHealth's revenue fell $79.5M (-10%) from $820M in Q1 2026 to $740M in Q2 2026.
What drove AdaptHealth's revenue change in Q2 2026?
Sleep Health +$28.0M (+8%); Wellness at Home +$18.4M (+13%); Respiratory Health +$16.3M (+9%).